No abstract

No abstract

No abstract

Background: Double-J (DJ) stents are among the basic and commonly used tools in urology. The DJ stent generally needs to be replaced or removed within 6 weeks to 6 months to avoid complications like encrustations, stone formation, fractures and blockades of stents. However, in many cases the stent is forgotten. In this retrospective study, we report our experience in the management of forgotten stents and steps taken by us in preventing DJ stent-related morbidity. Results: Of the total of 30 patients, 80% (n = 24) underwent previous procedures in other hospitals and the remaining 20% (n = 6) were from our hospital. The mean age of the patients was 56.66 years. The mean duration of the indwelling stent in situ was 13.83 months. The indications of indwelling stents included ureteroscopic lithotripsy, extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. Presenting complaints for which patients visited hospital were flank pain (n = 10; 33.33%), dysuria (n = 9; 30%), hematuria (n = 3, 10%) and fever (n = 2; 6.66%). Conclusion: Forgotten DJ stents can be a source of severe morbidity. Patients' and relatives' educational level and counseling before and after the procedure may play a significant role in reducing stent-related complications.

Breast cancer is the most common malignancy diagnosed worldwide. Breast cancer management represents an exemplary model of multidisciplinary management. The combined modality approach to treatment of breast cancer that includes primary surgery, radiation therapy, chemotherapy needs careful integration of these modalities with new methods of reconstructive breast surgery. The multidisciplinary approach has been associated with a reduction in breast cancer mortality. We present an interesting case of infiltrating ductal carcinoma, who presented as a locally advanced breast cancer in a very young patient who underwent neoadjuvant chemotherapy followed by modified radical mastectomy and primary breast reconstruction with latissimus dorsii flap. Our patient has recovered without any complications and is being prepared for adjuvant chemotherapy. All patients should undergo receptor testing which helps us in individualizing the treatment. The choice between breast conservation and mastectomy after neoadjuvant treatment is dependent on the treatment response and patient characteristics.